ABSTRACT
The increased use of self-luminous displays, especially in the evening prior to bedtime, has been associated with melatonin suppression, delayed sleep and sleep curtailment. The present study set out to investigate whether the Night Shift application provided by Apple Inc. for use on its portable electronic devices is effective for reducing acute melatonin suppression, a well-established marker of circadian phase. Participants experienced four experimental conditions: a dim light control, a high circadian stimulus true positive intervention and two Night Shift interventions delivering low and high correlated colour temperature light from the devices. Melatonin suppression did not significantly differ between the two Night Shift interventions, which indicates that changing the spectral composition of self-luminous displays without changing their brightness settings may be insufficient for preventing impacts on melatonin suppression.
ABSTRACT
This study investigated how light exposure duration affects melatonin suppression, a well-established marker of circadian phase, and whether adolescents (13-18 years) are more sensitive to short-wavelength (blue) light than adults (32-51 years). Twenty-four participants (12 adolescents, 12 adults) were exposed to three lighting conditions during successive 4-h study nights that were separated by at least one week. In addition to a dim light (<5 lux) control, participants were exposed to two light spectra (warm (2700 K) and cool (5600 K)) delivering a circadian stimulus of 0.25 at eye level. Repeated measures analysis of variance revealed a significant main effect of exposure duration, indicating that a longer duration exposure suppressed melatonin to a greater degree. The analysis further revealed a significant main effect of spectrum and a significant interaction between spectrum and participant age. For the adolescents, but not the adults, melatonin suppression was significantly greater after exposure to the 5600 K intervention (43%) compared to the 2700 K intervention (29%), suggesting an increased sensitivity to short-wavelength radiation. These results will be used to extend the model of human circadian phototransduction to incorporate factors such as exposure duration and participant age to better predict effective circadian stimulus.
ABSTRACT
In addition to stimulating the visual system, light incident on the retina stimulates other biological functions, also referred to as non-visual responses. Among the most notable biological functions are human circadian rhythms, which are bodily rhythms that, in constant darkness, oscillate with a period close to, but typically slightly longer than 24 hours. Twenty-four-hour light-dark patterns incident on the retina are the major synchronizer of circadian rhythms to the local time on Earth. Entrainment of circadian rhythms has been implicated in health and well-being. Light can also elicit an acute alerting effect on people, similar to a "cup of coffee." This review summarizes the literature on how light affects entrainment and alertness and how it can be used to achieve these aims.
ABSTRACT
Water buffaloes (Bubalus bubalis) are quite well adapted to climatic conditions in the Amazon, and in this biome, they are noted for the considerable amount of meat and milk they produce and how hard they are able to work. Because of a lack of research dedicated to improving the rearing of buffaloes in the Amazon, the objective of this study was to genetically characterize the Murrah and Mediterranean breeds, as well as a mixed-breed population, based on polymorphisms in the diacylglycerol O-acyltransferase 1 gene (DGAT1), and associate the genotypes with milk production. By using the polymerase chain reaction-single-strand conformation polymorphism technique, the alleles A (0.79), B (0.20), and D (0.01) were found in the Murrah breed. In the Mediterranean and mixed-breed buffaloes, we found alleles A (0.69) and (0.77) and B (0.31) and (0.23), respectively. The Murrah breed had the genotypes AA (0.63), AB (0.29), BB (0.05), and AD (0.03), and the Mediterranean and mixed-breed buffaloes had the genotypes AA (0.44) and (0.61), AB (0.50) and (0.31), and BB (0.06) and (0.08), respectively. For the Murrah, Mediterranean, and mixed-breed buffaloes, respectively, the expected heterozygosity values were 0.34, 0.43, and 0.35, the inbreeding coefficients were 0.78, -0.15, and 0.17, and the Hardy-Weinberg probabilities were 0.70, 0.67, and 0.52. The genotypes evaluated did not have an effect on milk production; however, the single nucleotide polymorphisms can be used in studies on genetic variability.
Subject(s)
Buffaloes/genetics , Diacylglycerol O-Acyltransferase/genetics , Genetic Variation , Alleles , Animals , Diacylglycerol O-Acyltransferase/metabolism , Genotype , Milk/metabolism , Polymorphism, Single Nucleotide/geneticsABSTRACT
Light can be used to consolidate sleep in individuals with Alzheimer's disease and related dementias, but the light delivery method is one of the greatest challenges for successful treatment. Based on our field observations, it was hypothesised that a self-luminous light table would be a practical way to deliver light because persons with Alzheimer's disease typically spend a significant amount of time sitting at tables. Compared to a baseline week, sleep percent and efficiency significantly increased and agitation and depression scores significantly decreased during the four intervention weeks. The self-luminous light table was an effective and practical method to deliver circadian-effective light to persons with Alzheimer's disease.
ABSTRACT
Sleep disorders are problematic for persons with dementia and their family caregivers. This randomized controlled trial with crossover evaluated the effects of an innovative blue-white light therapy on 17 pairs of home-dwelling persons with dementia and their caregivers. Subjects with dementia received blue-white light and control ('red-yellow' light) for six weeks separated by a four-week washout. Neither actigraphic nor most self-reported sleep measures significantly differed for subjects with dementia. For caregivers, both sleep and role strain improved. No evidence of retinal light toxicity was observed. Six weeks of modest doses of blue-white light appear to improve sleep in caregivers but not in persons with dementia. Greater or prolonged circadian stimulation may be needed to determine if light is an effective treatment for persons with dementia.
ABSTRACT
The objective of the study was to perform a literature review on the health consequences of working rotating shifts and implications for structural design. A literature search was performed in June 2012 and a selection of the most relevant peer-review articles was included in the present review. Shift workers are more likely to suffer from a circadian sleep disorder characterized by sleepiness and insomnia. Shift work is associated with decreased productivity, impaired safety, diminished quality of life and adverse effects on health. Circadian disruption resulting from rotating shift work has also been associated with increased risk for metabolic syndrome, diabetes, cardiovascular disease and cancer. This article summarizes the known health effects of shift work and discusses how light can be used as a countermeasure to minimize circadian disruption at night while maintaining alertness. In the context of the lighted environment, implications for the design of newborn intensive care units are also discussed.
Subject(s)
Hospital Design and Construction , Occupational Health , Sleep Disorders, Circadian Rhythm/complications , Animals , Breast Neoplasms/epidemiology , Circadian Rhythm/physiology , Humans , Intensive Care Units, Neonatal , Lighting , Melatonin/physiology , Neoplasms/epidemiology , Neoplasms/physiopathology , Quality of Life , Risk Factors , Sleep Disorders, Circadian Rhythm/physiopathology , Sleep Disorders, Circadian Rhythm/prevention & controlABSTRACT
This paper documents the spectral and spatial performance characteristics of two new versions of the Daysimeter, devices developed and calibrated by the Lighting Research Center to measure and record personal circadian light exposure and activity levels, and compares them to those of the Actiwatch Spectrum (Philips Healthcare). Photometric errors from the Daysimeters and the Actiwatch Spectrum were also determined for various types of light sources. The Daysimeters had better photometric performance than the Actiwatch Spectrum. To assess differences associated with measuring light and activity levels at different locations on the body, older adults wore four Daysimeters and an Actiwatch Spectrum for five consecutive days. Wearing the Daysimeter or Actiwatch Spectrum on the wrist compromises accurate light measurements relative to locating a calibrated photosensor at the plane of the cornea.
ABSTRACT
UNLABELLED: Alzheimer's disease (AD) is expected to affect more than 22 million people worldwide by 2025, causing devastating suffering and enormous costs to families and society. AD is a multifactorial disease, with a complex pathological mosaic. In rodents, AD-like dementia can be induced by cerebral microinjection of Aß peptide, leading to amyloid deposits, amnesia and various features of neurodegeneration. Marapuama (Ptychopetalum olacoides) is regarded as a "brain tonic" in the Amazon region and shows a nootropic profile in rodents. AIM OF THE STUDY: Because a specific extract (POEE) of Marapuama was shown to possess promnesic and anti-amnesic properties, the aim of this study was to verify if POEE is also effective against Aß(1-42)-induced cognitive deficit in mice. Additionally, Aß deposits (Congo red), GFAP immunoreactivity (immunohistochemistry), and neurodegenerative changes in the hippocampal pyramidal layer (Nissl) were examined as measures of Aß(1-42)-induced neurodegeneration. MATERIALS AND METHODS: CF1 mice were subjected to the experimental Alzheimer model with the Aß(1-42) i.c.v. administration. The effects of POEE 800 mg/kg were evaluated over 14 consecutive days of treatment. RESULTS: The data show that 14 days of oral treatment with POEE (800 mg/kg) was effective in preventing Aß-induced cognitive impairment, without altering the levels of BDNF and with parallel reductions in Aß deposits and astrogliosis. CA1 hippocampus loss induced by Aß(1-42) was also diminished in POEE-treated mice. CONCLUSION: This study offers evidence of functional and neuroprotective effects of two weeks treatment with a Ptychopetalum olacoides extract against Aß peptide-induced neurotoxicity in mice. Given the multifactorial nature of neurodegeneration, the considerable potential for an AChE inhibitor displaying associated neuroprotective properties such as here reported warrants further clinic evaluation.
Subject(s)
Cognition Disorders/drug therapy , Nerve Degeneration/drug therapy , Nootropic Agents/pharmacology , Olacaceae/chemistry , Phytotherapy , Plant Extracts/pharmacology , Alzheimer Disease/drug therapy , Amyloid beta-Peptides/pharmacology , Animals , Brain/drug effects , Dementia/drug therapy , Disease Models, Animal , Disease Progression , Male , Mice , Neuroglia/pathology , Nootropic Agents/therapeutic use , Peptide Fragments/pharmacology , Plant Extracts/therapeutic use , Plants, Medicinal/chemistryABSTRACT
The goal of acetylcholinesterase inhibitors (AChEIs) used to treat Alzheimer's patients is an improvement in cholinergic transmission. While currently available AChEIs have limited success, a huge impediment to the development of newer ones is access to the relevant brain areas. Promnesic, anti-amnesic and AChEI properties were identified in a standardized ethanol extract from Ptychopetalum olacoides (POEE), a medicinal plant favored by the elderly in Amazon communities. The purpose of this study was to provide conclusive evidence that orally given POEE induces AChE inhibition in brain areas relevant to cognition. Histochemistry experiments confirmed that the anticholinesterase compound(s) present in POEE are orally bioavailable, inducing meaningful AChE inhibition in the hippocampus CA1 (â¼33%) and CA3 (â¼20%), and striatum (â¼17%). Ellman's colorimetric analysis revealed that G1 and G4 AChE isoforms activities were markedly inhibited (66 and 72%, respectively) in hippocampus and frontal cortex (50 and 63%, respectively), while G4 appeared to be selectively inhibited (72%) in the striatum. Western blotting showed that POEE did not induce significant changes in the AChE immunocontent suggesting that its synthesis is not extensively modified. This study provides definitive proof of meaningful anticholinesterase activity compatible with the observed promnesic and anti-amnesic effects of POEE in mice, reaffirming the potential of this extract for treating neurodegenerative conditions where a hypofunctioning cholinergic neurotransmission is prominent. Adequate assessment of the safety and efficacy of this extract and/or its isolated active compound(s) are warranted.
Subject(s)
Acetylcholinesterase/metabolism , Brain/drug effects , Cholinesterase Inhibitors/pharmacology , Nootropic Agents/pharmacology , Olacaceae , Phytotherapy , Plant Extracts/pharmacology , Animals , Cognition/drug effects , Male , Mice , Mice, Inbred Strains , Neurodegenerative Diseases/drug therapy , Plant Roots , Protein IsoformsABSTRACT
Aromatherapy uses essential oils (EOs) for several medical purposes, including relaxation. The association between the use of aromas and a decrease in anxiety could be a valuable instrument in managing anxiety in an ever increasing anxiogenic daily life style. Linalool is a monoterpene commonly found as the major volatile component of EOs in several aromatic plant species. Adding to previously reported sedative effects of inhaled linalool, the aim of this study was to investigate the effects of inhaled linalool on anxiety, aggressiveness and social interaction in mice. Additionally, we investigated the effects of inhaled linalool on the acquisition phase of a step-down memory task in mice. Inhaled linalool showed anxiolytic properties in the light/dark test, increased social interaction and decreased aggressive behavior; impaired memory was only seen the higher dose of linalool. These results strengthen the suggestion that inhaling linalool rich essential oils can be useful as a mean to attain relaxation and counteract anxiety.
Subject(s)
Aggression/drug effects , Anti-Anxiety Agents/therapeutic use , Aromatherapy , Behavior, Animal/drug effects , Monoterpenes/therapeutic use , Oils, Volatile/therapeutic use , Plant Extracts/therapeutic use , Acyclic Monoterpenes , Administration, Inhalation , Animals , Anti-Anxiety Agents/pharmacology , Anxiety/drug therapy , Darkness , Light , Male , Memory/drug effects , Mice , Monoterpenes/adverse effects , Monoterpenes/pharmacology , Oils, Volatile/pharmacology , Plant Extracts/pharmacologyABSTRACT
This work has investigated the effects of prolonged exposure of young rats to nicotine on some physiological and biochemical parameters. Wistar male rats (30 days old) were treated (s.c.) with saline or nicotine 5mg/kg/day for 28 or 56 days. They received five injections (1mg/kg) per day (8, 10, 12:00 a.m., 2 and 4:00 p.m.) on the dark period of the cycle. Nicotine exposure for 56 days reduced body and liver weights. Moreover, nicotine exposure for 28 or 56 days decreased the hepatic glycogen but not blood glucose levels. The activities of blood and hepatic PBG-synthase, and blood and cerebral acetylcholinesterase were not affected by in vivo exposure. However, these activities were inhibited by nicotine in vitro. Results show that although high levels of plasma cotinine were found in both intervals of exposures, the parameters here analyzed were not affected by prolonged nicotine exposure except the storage of glucose, and body and liver weights.
Subject(s)
Aging/drug effects , Nicotine/toxicity , Acetylcholinesterase/metabolism , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Brain/drug effects , Brain/enzymology , Cotinine/blood , Environmental Exposure , Injections, Subcutaneous , Liver/anatomy & histology , Liver/drug effects , Male , Nicotine/administration & dosage , Organ Size/drug effects , Rats , Rats, WistarABSTRACT
O artigo não apresenta resumo.
ABSTRACT
The article has no abstract.
ABSTRACT
O artigo não apresenta resumo.
ABSTRACT
Human adult males were exposed to combinations of two illuminances and two spectral power distributions over the course of four nighttime sessions. A dose-dependent response of acute melatonin suppression to light was found, but photopic (cone-based) illuminance did not adequately predict suppression. When melatonin suppression was plotted against scotopic (rod-based) illuminance, the data formed a nearly monotonic function, implicating rods, or a rod-dominated mechanism, in the human melatonin regulation system. The results do not, however, rule out mechanisms other than rods, including novel photoreceptors, as candidates for melatonin regulation in humans.
Subject(s)
Circadian Rhythm/physiology , Darkness , Light Signal Transduction/physiology , Light , Melatonin/metabolism , Retinal Rod Photoreceptor Cells/physiology , Adult , Dark Adaptation/physiology , Humans , Male , Melatonin/blood , Middle Aged , Photic Stimulation/methods , Pineal Gland/metabolism , Radioimmunoassay , Retinal Cone Photoreceptor Cells/physiologyABSTRACT
Um caso de fistula nefroapendico cutanea e apresentado, salientando-se sua raridade quando o processo e primariamente renal